Director responsible for onboarding new liquid alternative instruments into Fidelity's investment operations. Coordinating with business partners to innovate scalable solutions in derivative middle and back office operations.
Responsibilities
Responsible for the onboarding of new alternative instruments into FFIO
Coordinating work needed to support various Asset Manager investment paths
Helping to define new service models
Driving innovation in building scalable solutions
Documenting requirements with business partners on new instrument intake
Identifying gaps and working with service lines and business partners to develop scalable solutions
Working with other teams within FFIO as well as across the organization
Requirements
Bachelor's degree or equivalent experience in Finance/Accounting
At least 6-8 years spent in either Derivative middle or back office operations
Advanced knowledge of the alternative fund industry and hedge fund products
Detailed instrument knowledge (including Cleared and OTC Swaps, Options, Futures, Loans, and other Alternatives)
Detailed understanding of the lifecycle of the complex instruments
Experience supporting middle and back-office operations of derivatives instruments is preferred
Excellent communication skills with the ability to develop and deliver cogent, informative presentations
Presence and judgment to put forward well-reasoned recommendations
Understanding of financial and accounting principles and how to apply them in business
Benefits
Comprehensive health care coverage and emotional well-being support
Market-leading retirement
Generous paid time off and parental leave
Charitable giving employee match program
Educational assistance including student loan repayment, tuition reimbursement, and learning resources to develop your career
Job title
Director, Liquid Alternative Instrument Readiness – Strategy
Director defining and executing strategies to enhance HP’s software and services portfolio. Leading cross - functional teams in high - visibility initiatives involving AI technologies and market strategies.
Intellectual Property leader providing legal support in managing IP risks and opportunities for Woodward's Aerospace segment. Ensuring compliance and fostering IP awareness across the organization.
Director of Secondary Cycle & Balance - of - Plant Performance at AtkinsRéalis, optimizing nuclear power output and operational costs. Leading team collaboration and strategy execution in engineering and quality standards.
Director responsible for scientific oversight and quality of clinical trials in Internal Medicine. Leading execution, protocol development, and safety management within Pfizer's clinical development team.
Associate Director, Clinical Pharmacology Lead supporting drug discovery and development for Pfizer's Internal Medicine portfolio. Collaborating with multifunctional teams and implementing innovative practices in drug development.
Managing Director overseeing a diversified investment portfolio from ~$300M to $1B+ AUM at Maropost. Leading strategic direction and implementing AI - enabled tools for financial planning and analysis.
Director role for Asset Owners Team at S&P Global focusing on commercial growth and revenue generation by managing U.S. and Canadian asset owner relationships. Leading business development efforts and delivering consultative solutions.
Director of Multi Line Account Engineering at Arch managing risk control portfolios for diverse lines. In - depth account management with focus on underwriting, partnership, and loss reduction strategies.
Director of Corporate Development managing M&A lifecycle and strategic partnerships at CSC Generation. Collaborating with CEO on inorganic growth strategy across retail and consumer sectors.
Director leading the consolidation and external reporting in finance for various stakeholders. Managing a diverse team and ensuring compliance with standards for group entities in finance.